Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00230672 |
Recruitment Status
: Unknown
Verified August 2008 by Imperial College London.
Recruitment status was: Recruiting
First Posted
: October 3, 2005
Last Update Posted
: August 13, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Telangiectasia, Hereditary Hemorrhagic |
Study Type : | Observational |
Estimated Enrollment : | 70 participants |
Time Perspective: | Prospective |
Official Title: | Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients |
Study Start Date : | March 2005 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:Patients with hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations -
Exclusion Criteria:Unable to provide informed consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00230672
Contact: Claire Shovlin | 0208 383 1000 | c.shovlin@imperial.ac.uk |
United Kingdom | |
Imperial College Hammersmith Campus | Recruiting |
London, United Kingdom, W12 0NN | |
Contact: Claire Shovlin 0208 383 1000 c.shovlin@imperial.ac.uk |
Principal Investigator: | Claire Shovlin | Imperial College London |
ClinicalTrials.gov Identifier: | NCT00230672 History of Changes |
Other Study ID Numbers: |
IC/CLS7 |
First Posted: | October 3, 2005 Key Record Dates |
Last Update Posted: | August 13, 2008 |
Last Verified: | August 2008 |
Additional relevant MeSH terms:
Arteriovenous Malformations Vascular Malformations Cardiovascular Abnormalities Congenital Abnormalities Telangiectasis Telangiectasia, Hereditary Hemorrhagic |
Vascular Diseases Cardiovascular Diseases Hemostatic Disorders Hemorrhagic Disorders Hematologic Diseases |